Ivabradine-Flecainide as Breakthrough Drug Combination for Congenital Junctional Ectopic Tachycardia: A Case Report and Literature Review
Congenital junctional ectopic tachycardia (CJET) is a rare tachyarrhythmia that remains difficult to manage, with suboptimal control in most cases. Here, we report literature research on the use of ivabradine in the treatment of pediatric junctional ectopic tachycardia (JET), both congenital and pos...
Saved in:
Main Authors: | Giovanni Maria Di Marco (Author), Angelica De Nigris (Author), Angela Pepe (Author), Annamaria Pagano (Author), Giangiacomo Di Nardo (Author), Vincenzo Tipo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ivabradine monotherapy in congenital junctional ectopic tachycardia
by: Sivalingam Devaprasath, et al.
Published: (2022) -
Ivabradine for congenital junctional ectopic tachycardia in siblings
by: Shyam S Kothari, et al.
Published: (2018) -
Use of ivabradine in pediatric post-operative junctional ectopic tachycardia
by: Eduardo López Fernández, et al.
Published: (2021) -
Flecainide toxicity in a preterm neonate with permanent junctional reciprocating tachycardia
by: Balaganesh Karmegaraj, et al.
Published: (2017) -
Flecainide intoxication in pediatric patients with supraventricular tachycardia
by: Guiem Vaquer, et al.
Published: (2020)